Table 2.
Outcomes | n | Estimated means (SE)
|
HIV infection (HIV+ vs. HIV−)
|
Probable PTSD (yes vs. no)
|
HIV×PTSD | |||||
---|---|---|---|---|---|---|---|---|---|---|
HIV−/PTSD− | HIV−/PTSD+ | HIV+/PTSD− | HIV+/PTSD+ | B (SE) | Cohen’s d | B (SE) | Cohen’s d | B (SE) | ||
Primary | ||||||||||
Verbal memory | 1496 | 50.3 (0.5) | 46.9 (1.3) | 48.4 (0.3) | 46.9 (0.7) | −1.66 (0.54)** | 0.17 | −2.13 (0.70)** | 0.22 | 1.95 (1.61) |
Delayed recall | 1496 | 50.1 (0.5) | 47.6 (1.4) | 48.3 (0.3) | 46.1 (0.8) | −1.81 (0.56)** | 0.18 | −2.30 (0.74)** | 0.23 | 0.39 (1.69) |
% retention | 1496 | 50.6 (0.5) | 46.3 (1.4) | 48.5 (0.4) | 47.7 (0.8) | −1.50 (0.59)* | 0.14 | −1.96 (0.77)* | 0.19 | 2.97 (1.70) |
Verbal learning | 1496 | 50.3 (0.4) | 48.4 (1.3) | 48.7 (0.3) | 46.7 (0.7) | −1.58 (0.52)** | 0.17 | −2.02 (0.68)** | 0.22 | −0.17 (1.56) |
Trial 1 | 1496 | 50.4 (0.5) | 48.2 (1.3) | 48.7 (0.3) | 47.2 (0.7) | −1.66 (0.55)** | 0.17 | −1.77 (0.71)* | 0.18 | 0.73 (1.64) |
Total trials 1–3 | 1496 | 50.1 (0.5) | 48.6 (1.4) | 48.8 (0.3) | 46.2 (0.7) | −1.51 (0.55)** | 0.15 | −2.28 (0.72)** | 0.23 | −1.07 (1.66) |
Secondary | ||||||||||
Attention | 1321 | 50.1 (0.4) | 49.1 (1.1) | 49.2 (0.3) | 48.9 (0.6) | −0.79 (0.43) | 0.11 | −0.60 (0.58) | 0.10 | 0.66 (1.31) |
Executive function | 1253 | 50.2 (0.4) | 49.5 (1.2) | 49.8 (0.3) | 49.2 (0.7) | −0.38 (0.51) | 0.04 | −0.64 (0.67) | 0.08 | 0.11 (1.51) |
Psychomotor speed | 1488 | 50.1 (0.5) | 48.0 (1.4) | 49.3 (0.3) | 45.9 (0.7) | −1.06 (0.56) | 0.11 | −2.93 (0.73)*** | 0.29 | −1.24 (1.68) |
Verbal fluency | 1487 | 49.7 (0.4) | 48.9 (1.2) | 49.7 (0.3) | 49.8 (0.7) | 0.17 (0.50) | 0.02 | −0.13 (0.66) | 0.01 | 0.92 (1.51) |
Fine motor skills | 1443 | 48.8 (0.5) | 46.1 (1.5) | 49.1 (0.4) | 50.5 (0.9) | 1.03 (0.61) | 0.09 | 0.11 (0.83) | 0.01 | 4.09 (1.85)* |
Results from inverse probability-weighted (IPW) linear regression analyses on the primary and secondary cognitive outcomes. Totals do not add to 1500 because not all women completed all cognitive tests due to participant refusal or other known (e.g., neuropathy) or unknown reasons
B parameter estimates, SE standard errors, n sample size
p<0.001;
p<0.01;
p<0.05